The DECISION consortium is looking forward to meet again face-to-face from 19-21 October 2022 in Madrid. This meeting will have a strong focus on results and paper-writing and it will serve to discuss the final steps before the start of the COMBAT trial later this year. 45 registered members will join forces to make progress on combinatorial therapies for patients with decompensated cirrhosis.